Fractures in a nationwide population-based cohort of users of breast cancer hormonal therapy

ConclusionsAlthough total nonvertebral fracture risk was higher among AI users, differences in hip fractures were not significant in a large population-based cohort of older women.Implications for Cancer SurvivorsUse of aromatase inhibitors by older women is associated with high risk for nonvertebral fracture that is increased compared with use of tamoxifen. Fracture risk should be assessed among patients taking these medications.
Source: Journal of Cancer Survivorship - Category: Cancer & Oncology Source Type: research